SEC Form 4 · accession 0001179110-16-022839
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew M Gosling
Officer — SVP, General Counsel
Period of report
Apr 2, 2016
Accepted (ET)
Apr 5, 2016 · 9:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 2, 2016 | F | 940 | $14.38 | D | 55,236 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock.
- F2Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.